713 related items for PubMed ID: 16968719
1. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
2. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 Nov; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
4. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I, Visvardis G, Papadopoulou D, Nakopolou L, Karanikas E, Gogos K, Stavianoudakis G.
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[Abstract] [Full Text] [Related]
5. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
6. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A, Takei T, Yoshida T, Tsuchiya K, Nitta K.
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[Abstract] [Full Text] [Related]
7. Cyclosporine experience in nephrotic syndrome.
Phadke K, Ballal S, Maiya V.
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[Abstract] [Full Text] [Related]
8. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, Li XM, Li XW.
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[Abstract] [Full Text] [Related]
9. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[Abstract] [Full Text] [Related]
10. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[Abstract] [Full Text] [Related]
11. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
Turk J Pediatr; 1999 Jun; 41(2):225-30. PubMed ID: 10770662
[Abstract] [Full Text] [Related]
12. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
[Abstract] [Full Text] [Related]
13. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P, Koutroulia E, Sotsiou F, Vlachojannis JG, Goumenos DS.
Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
[Abstract] [Full Text] [Related]
14. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[Abstract] [Full Text] [Related]
15. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
16. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[Abstract] [Full Text] [Related]
17. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[Abstract] [Full Text] [Related]
18. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[Abstract] [Full Text] [Related]
19. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
[Abstract] [Full Text] [Related]
20. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
